You are here: Industry Insights > Dr Reddy

News List

Warning letter woes: Dr Reddy’s expects FDA inspection of AP plant by year-end expresspharma
August 02, 2019
US FDA had issued warning letter in November 2015 relating to Current Good Manufacturing Practice deviations at Dr Reddy’s API manufacturing facilities at Srikakulam.
Dr Reddy’s launches insomnia treatment tablets in US expresspharma
July 26, 2019
Drug major Dr Reddy’s Laboratories has said it has launched generic Ramelteon tablets used for treatment of insomnia in the US market. The company has launched Ramelteon tablets in the strength of ...
Dr Reddy’s launches generic version of Allegra D in US expresspharma
July 23, 2019
Drug major Dr Reddy’s Laboratories said it has launched generic Allegra-D, used to relieve symptoms caused by the common cold, flu or allergies, in the US market.
Dr Reddy’s announces closure of the transaction to divest Zembrace SymTouch and Tosymra to Upsher-Smith expresspharma
July 23, 2019
Dr Reddy’s Laboratories announced the closure of the transaction with Upsher-Smith Laboratories after the satisfactory completion of all customary closing conditions including the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvement
US FDA issues 5 observations to Dr Reddy’s plant in Hyderabad expresspharma
July 18, 2019
Dr Reddy’s Laboratories said the US health regulator has issued five observations after audit of a company’s plant in Hyderabad.
Budget reactions 2019 expresspharma
July 08, 2019
The expectations from the Union Budget 2019 were that of a bold reformist budget, however, it turned out to be an incremental budget at best.
Price erosion symptoms: Dr Reddy’s Laboratories plans to launch value-added drugs in US expresspharma
July 08, 2019
Maintaining that pricing pressure will continue in the US market, Dr Reddy’s Laboratories has said the company plans to launch several value-added products this fiscal to offset the persisting problem.
Dr Reddy’s launches generic Hemabate injection in US market expresspharma
July 04, 2019
Carboprost Tromethamine is used to treat severe bleeding after childbirth (postpartum) and is also used to produce an abortion by causing uterine contractions
Dr Reddy’s launches in Phytonadione Injectable Emulsion USP in US market expressbpd
June 27, 2019
Dr Reddy’s Phytonadione Injectable Emulsion USP, 10 mg/ml Single-Dose Ampules is available in 1 mL Ampule containing 10 mg/mL of Phytonadione
Dr Reddy’s launches Tobramycin Inhalation Solutionin US Market expressbpd
June 27, 2019
Dr Reddy’s Tobramycin Inhalation Solution, USP is available in a 300 mg/5 mL, single-dose Ampule

Previous page 1 2 3 4 5 Next page